{
    "nctId": "NCT02509871",
    "briefTitle": "Study of Body Composition in Patients Treated by Adjuvant Hormonal Therapy for Breast Cancer (MetaCa2)",
    "officialTitle": "Study of Body Composition in Patients Treated by Adjuvant Hormonal Therapy for Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Hormonal Therapy, Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "BASIC_SCIENCE",
    "enrollmentCount": 33,
    "primaryOutcomeMeasure": "Measure of body composition",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* postmenopausal women\n* patients requiring hormonal treatment\n* WHO performance status 0-2\n* patients initially included in MetaCa (AU882) protocol\n* Affiliation to a social security scheme (or be the beneficiary of such a plan)\n* patients who signed the informed consent form\n\nExclusion Criteria:\n\n* patients witg relapse, with metastases or other cancer\n* concurrent treatment with a drug test, or participation in a clinical trial within \\< 30 days\n* patients carrying an electronic medical device (eg pacemaker)\n* patients who refused to sign the consent form",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}